Table 1. Increased scyllo-inositol in frontal cortex and hippocampus in triple transgene mice using HRMAS.
Chemical/Cr | Frontal Cortex | Hippocampus | ||
---|---|---|---|---|
Scyllo (n=5) | Reg (n=3) | Scyllo (n=7) | Reg (n=7) | |
GABA | 0.306±.041 | 0.362±.138 | 0.356±.157 | 0.315±.053 |
Acetate | 0.033±.009 | 0.039±.006 | 0.049±.017 | 0.053±.022 |
Alanine | 0.075±.008 | 0.084±.007 | 0.060±.019 | 0.066±.013 |
Aspartate | 0.350±.037 | 0.317±.080 | 0.366±.082 | 0.334±.042 |
Choline | 0.286±.034 | 0.258±.043 | 0.171±.049 | 0.196±.076 |
Glutamate | 1.132±.135 | 1.106±.099 | 0.667±.114 | 0.679±.063 |
Glutamine | 0.360±.060 | 0.394±.053 | 0.458±.107 | 0.368±.031 |
Glycine | 0.116±.017 | 0.112±.004 | 0.131±.023 | 0.134±.025 |
Lactate | 0.806±.081 | 0.689±.055 | 0.961±.183 | 0.819±.228 |
NAA | 0.825±.069 | 0.796±.075 | 0.534±.067 | 0.485±.078 |
Scyllo-Inositol | 0.035±.008* | 0.016±.003 | 0.074±.018* | 0.031±.011 |
Taurine | 1.580±.215 | 1.553±.277 | 1.07±.230 | 0.986±.133 |
myo-Inositol | 0.736±.112 | 0.759±.170 | 0.701±.110 | 0.748±.114 |
Concentrations reported as molar ratios to creatine.
Errors reported are standard deviations.
p<0.001; t-test corrected for multiple comparisons